ABSTRACT
INTRODUCTION
Osteoporosis is the most common of all the metabolic bone disorders and is an important cause of morbidity in our country. The normal balance between bone formation and resorption is known as remodeling of the bone. It is a continuous process, which results in the maintenance of the skeletal mass. In osteoporosis, the bone mass is decreased, indicating that the rate of bone resorption must exceed that of bone formation. The difference is exaggerated by menopause (1) and longevity (2, 3) . When peak adult bone mass is reached at about age 30-35 years, rates of bone formation and resorption are relatively low and approximately equal. The common causes
The Osteoblastic markers Alkaline Phosphatase (ALP), Inorganic Phosphorus (Pi) and Free or ionic calcium (Ca ++ ) also undergo alteration in the osteoporosis scenario (6) . Vitamins E and C are antioxidant vitamins, which exert their osteoprotective effect (5) by curbing the excessive free radicals formation and thereby controlling the MDA levels, which indicate the lipid peroxidation in the body. The genesis of present study is the observation of hyperoxidant stress in osteoporosis as seen in the pilot study (6) . It is to be seen, whether the antioxidant supplements help to alleviate the oxidative stress in the osteoporotic patients, and if so, their efficacy. attending the OPD and fifty healthy controls were enrolled in the study. All patients and control group individuals gave informed consent for the study. The control group individuals were in the age group of 20-50 years; were not suffering from any disease and were not on any medication before and during the study period. Smokers were excluded. The osteoporotic patients were in the age group between 45-70 years. The subjects were divided into three groups of 25 patients each for administration of antioxidants for a period of 90 days. Group A -Vitamin E (Evinal 400 mg); Group B -Vitamin C (Celin 500 mg) and Group C -Vitamin E + C (Celin + Evinal) Samples were collected and analyzed at 45 and 90 days.
MATERIALS AND METHODS

The
Patients already on antioxidant supplementation or antiresorptive therapy, at the time of enrollment were excluded. Patients suffering from non-osteoid metabolic disorders like Diabetes Mellitus and Hyperparathyroidism were also excluded.
After overnight 12 hours fasting, basal sample (10 ml whole blood) was collected, under aseptic conditions, from both the control and study groups. Seven ml of it was collected in a plain sterile bulb for the estimation of ALP; Pi, SOD and MDA and 100 PL serum was kept for the measurement of TrACP. Three ml of whole blood was collected anaerobically in a capped conical centrifuge tube for the free calcium estimation. One ml of whole blood was collected in the acid citrate dextrose (ACD) bulb for the erythrocyte reduced glutathione estimation.
Samples were collected and analyzed for biochemical markers within 3 hours of sample collection by the following methodologies:
SOD by Marklund and Marklund (7), MDA Wilbur et al (8) , ALP by kinetic method (9), Pi by Fiske Subbarrow (10), Tartarate resistant acid phosphatase (TrACP) by kinetic method (11) , Ca ++ by ion selective electrode (12) and Erythrocyte reduced glutathione (GSH) by Beutler et al (13) .
Statistical analysis was performed using ANOVA software, which involves paired and unpaired t-tests. Mean values and SD were calculated for every variable in each group and were compared between different groups. The 0.05 as point of minimal statistical significance.
RESULTS AND DISCUSSION
The baseline levels of osteoclastic markers namely serum MDA and TrACP are significantly increased in osteoporosis as compared with controls (p < 0.001, p < 0.01). The baseline levels of osteoblastic marker ALP, are significantly raised (p < 0.01) while there is no change in concentration of serum Ca ++ and Pi. The antioxidant marker i.e. serum SOD is significantly Value are Mean ± SD, *p < 0.01; **p < 0.001 increased ( p < 0.02 ) while no significant rise in concentration of erythrocyte GSH (Table I) .
Vitamin E Supplementation
The osteoclastic markers i.e. serum MDA and TrACP showed significant decrease after 45 days and 90 days of antioxidant supplementation (p< 0.001, p<0.01). The osteoblastic markers serum ALP showed non significant decrease at 45 and 90 days but concentration of Ca ++ showed statistically significant decrease at 45 and 90 days (p< 0.001). No significant change was observed in serum phosphorus levels after 45 and 90 days of vitamin E supplementation (Table II) .
The antioxidant status of the body improved in terms of serum SOD concentration at 45 and 90 days (p< 0.001) and non significant change in erythrocyte GSH concentration.
Vitamin C Supplementation
The osteoclastic markers i.e. serum MDA and TrACP showed significant decrease after 45 days and 90 days of antioxidant supplementation (p< 0.001, p<0.001). The osteoblastic markers serum ALP showed significant decrease only at 90 days (p<0.01) but concentration of Ca ++ showed statistically significant decrease at 45 and 90 days (p< 0.04). No significant change was observed in serum phosphorus levels after 45 and 90 days of vitamin C supplementation (Table III) .
The antioxidant status of the body improved in terms of serum SOD concentration at 45 days (p< 0.05) and at 90 days (p< 0.001) also there is significant rise in erythrocyte GSH concentration at 90 days (0.001).
Vitamin E + C Supplementation
The osteoclastic markers i.e. MDA showed significant decrease after 45 days and 90 days of antioxidant supplementation (p< 0.001). However activity of TrACP was not changed at 45 and 90 days. The osteoblastic markers ALP and Pi showed non significant decrease at 45 and 90 days but concentration of Ca ++ showed significant decrease at 90 days only (p< 0.01). The antioxidant status of the body improved in terms of significant rise ( p<0.001) in serum SOD concentration and erythrocyte GSH concentration at 90 days (Table IV) .
The present study examined whether the antioxidant vitamin supplements could alleviate the adverse effects in the bone profile seen in osteoporosis. In Osteoporosis, which sets in because of longevity, menopause, smoking, alcoholism, Value are Mean ± SD; *p < 0.01; **p < 0.001 Value are Mean ± SD; *p < 0.01; **p < 0.001
Oxidative Stress and Osteoporosis malnutrition, immobilization, calcium deficiency and many nonosteoid disorders, there is excessive osteoclastic activity in the bone, resulting in increased free radicals formation and hence, enhanced lipid peroxidation, culminating in imbalance between bone formation and resorption and adverse alteration in the normal bone remodeling (14) (15) (16) . This picture is reflected by higher levels of MDA, osteoclastic marker i.e. TrACP and osteoblastic markers (ALP) and raised serum SOD levels in the osteoporotic patients as compared to control group.
The rise in serum MDA in osteoporosis may be because of overwhelming osteoclastic activity due to activation of osteoclasts. One important component is generation of superoxide radical (17) . Normally this molecule is responsible for bone remodeling (18) , when produced in excess it leads to oxidative stress if not metabolized by Superoxide dismutase i.e. SOD (19) . This study reveals no change in erythrocyte GSH concentration that may explain rise in serum MDA levels is occurring due to increased lipid peroxidation inspite of raised serum SOD levels.
The other osteoclastic marker TrACP showed significant fall at 45 and 90days of vitamin E and C supplementation individually. Ca ++ also showed fall that indicates mineralisation is occurring, as there is balance between osteoclastic and osteoblastic activities.
The significant rise in serum SOD and erythrocyte GSH after supplementation of vitamins C individually and conjointly E + C at 90 days indicates an improvement in the antioxidant status of the body.
Vitamin E exerts its antioxidant property by preventing chain propagation as a result of its ability to transfer phenolic hydrogen to a peroxyl free radical of a peroxidized polyunsaturated fatty acid, minimizing the lipid peroxidation. The major portion of peroxytocopherol so formed, is reconverted to tocopherol by vitamin C and small amount is excreted as such in the bile (5).
Vitamin C acts as water a soluble antioxidant by inhibiting initiation of lipid peroxidation It also acts as a cofactor for NADP reductase required for glutathione metabolism (2, 16) .
The combined regimen of vitamin E and C does not seem to more effective compared to individual vitamin supplementation because of less availability of vitamin C in the osteoclasts, in response to its shunting for the recycling of vitamin E, in reconverting peroxytocopherol to tocopherol.
Thus the present study suggests that prolonged antioxidant vitamin supplementation may be beneficial in treatment of osteoporosis with no change in the efficacy of antioxidant vitamin (E and C) supplementation whether administered individually or conjointly.
